Center for Scientific Review; Notice of Closed Meeting, 75605 [2023-24277]
Download as PDF
<![CDATA[
75605
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Notices
Information in the SWP describes the
timeframes and progress required
during the grant period of performance
to address each of the needs detailed in
the Purpose and Need section of the
application, as required in the Notice of
Funding Opportunity announcement.
Applicants use the SWP form when they
submit their proposals, and award
recipients and Project Officers use the
SWP information to assist in monitoring
progress once HRSA makes the awards.
After awards are made, recipients
complete a Quarterly Progress Update
(QPU) to provide information to BHW
on a quarterly basis on each activity
listed in the SWP.
A 60-day notice published in the
Federal Register on August 25, 2023,
vol. 88, No. 164; pp. 58284–85. There
were no public comments.
Need and Proposed Use of the
Information: Information collected by
the SWP form and QPUs standardizes
and streamlines the data used by HRSA
in reviewing applications and
monitoring awardees. The form asks
applicants to provide a description of
the activities or steps the applicant will
take to achieve each of the objectives
proposed during the entire period of
performance. The current standardized
format and data submission by
applicants increases efficiency in
reviewing, awarding, and monitoring
each project.
The QPU is completed via HRSA’s
Electronic Handbook system and
prompts recipients to report on progress
of activities that were submitted using
the SWP in the original application. The
QPU automatically populates activities
from the recipient’s SWP form on a
quarterly basis. For each activity listed
in the submitted SWP for any particular
quarter within the project period,
recipients select and submit a single
selection response for each activity
status from a pull-down menu with five
options: Activity is on Schedule,
Activity is Complete, Timing is off
track, Activity will be missed if action
is not taken, and Activity cannot be
achieved. Information provided is
utilized by the program staff to regularly
assess overall progress of program
requirements and analyze data in order
to monitor award recipient compliance
and track progress against proposed
targets and goals. Information gathered
allows an improved and more efficient
method for identifying whether projects’
goals are being advanced or achieved, as
set forth in 45 CFR 75.342. Program staff
also use information provided over the
period of performance to see emerging
trends and to assess whether an award
recipient requires technical assistance to
address challenges that the award
recipient may be experiencing with the
implementation of the project. Seeking
OMB extension approval comports with
the regulatory requirement imposed by
45 CFR 75.206(a), Paperwork clearances.
Likely Respondents: Respondents are
applicants for, and recipients of, BHW’s
research and training grants and
cooperative agreements.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total annual
burden hours
Standardized Work Plan (SWP) ..........................................
Quarterly Progress Update (QPU) Form .............................
1,000
1,000
1
4
1,000
4,000
1.00
.10
1,000
400
Total ..............................................................................
1 1,000
........................
5,000
........................
1,400
1 The
1,000 SWP respondents reflects the number of new grant applications submitted annually. The 1,000 QPU respondents reflects the current volume of funded, active grants.
Maria G. Button,
Director, Executive Secretariat.
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2023–24273 Filed 11–2–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
VerDate Sep<11>2014
17:02 Nov 02, 2023
Jkt 262001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Advancing
Therapeutics II.
Date: November 14, 2023.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lystranne Alysia Maynard
Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
PO 00000
Frm 00069
Fmt 4703
Sfmt 9990
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–4809,
lystranne.maynard-smith@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 30, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–24277 Filed 11–2–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Notices]
[Page 75605]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24277]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Advancing Therapeutics II.
Date: November 14, 2023.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lystranne Alysia Maynard Smith, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-
402-4809, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 30, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-24277 Filed 11-2-23; 8:45 am]
BILLING CODE 4140-01-P
